Stroke and Risk Factors in Antiphospholipid Syndrome.
Yangyi FanYicheng XuSifan ZhangXiaodong SongZunjing LiuWen-Jun TuChun LiPublished in: Journal of personalized medicine (2023)
Stroke is considered one of the most common and life-threatening manifestations of antiphospholipid syndrome (APS), which leads to high mortality and permanent disability. This study investigated the prevalence and the potential risk factors of stroke in APS. We enrolled 361 APS patients retrospectively from 2009 to 2022 at Peking University People's Hospital. Stroke was found in 25.8% (93/361) of the participants. The multivariate logistic regression showed that hypertension, diabetes, livedo reticularis, and other central nervous system involvements were significant related factors for stroke. The use of hydroxychloroquine appeared to relate to a lower incidence of stroke. During a median follow-up of 3.0 years, 11.8% (11/93) of the individuals with a previous stroke developed stroke recurrence, and thrombocytopenia seemed to be a predictor of stroke recurrence.
Keyphrases
- atrial fibrillation
- risk factors
- type diabetes
- cardiovascular disease
- end stage renal disease
- multiple sclerosis
- healthcare
- chronic kidney disease
- coronary artery disease
- mass spectrometry
- high resolution
- newly diagnosed
- adipose tissue
- cardiovascular events
- peritoneal dialysis
- skeletal muscle
- patient reported outcomes
- subarachnoid hemorrhage
- cerebrospinal fluid
- insulin resistance
- drug induced
- patient reported